Abstract
FDG PET is well recognized for its utility in cancer workup. Nonetheless, the differentiation between malignant and benign pulmonary lesions by FDG PET is challenging. The authors report three proved cases of pulmonary tuberculosis in acute active and open stages. The activities and extents of infection were demonstrable in FDG PET, which could not be observed in either chest radiograph or computed tomography.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gutowski TD, Fisher SJ, Moon S, Wahl RL. Experimental studies of 18-F-2-fluoro-2-deoxy-d-glucose (FDG) in infection and in reactive lymph, nodes.J Nucl Med 1992; 33: 925. (abstract)
Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, et al. FDG-PET in infectious lesions: The detection and assessment, of lesion activity.Ann Nucl Med 1996; 10: 185–191.
Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis.Clin Nucl Med 1998; 23: 739–742.
Yen RF, Chen ML, Liu FY, Ko SC, Chang YL, Chieng PU, et al. False-positive 2-[F-18]-fluoro-2-deoxy-d-glucose positron emission, tomography studies for evaluation of focal pulmonary abnormalities.J Formos Med Assoc 1998; 97: 642–645.
Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxy-glucose positron-emission-tomography scanning: potential for error in interpretation.Semin Nucl Med 1996; 26: 308–314.
Mariani F, Goletti D, Ciaramella A, Martino A, Colizzi V, Fraziano M. Macrophages response toMycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis.Current Molecular Medicine 2001; 1: 209–216.
Lawn SD, Butera ST, Shiunick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response toMycobacterium tuberculosis.Microbes and Infection 2002; 4: 635–646.
Knight SB, Delbeke D, Stewart, JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparision of findings in patients with and without a history of prior malignancy.Chest 1996; 109: 982–988.
Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased18F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation.J Nucl Med 2002; 43: 658–663.
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.J Nucl Med 1995; 36: 1301–1306.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratuoral distribution of fluorine-18-fluorodeoxy-glucosein vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography.J Nucl Med 1992; 33: 1972–1980.
Knopp MV, Bischoff, HG. Evaluation of pulmonary lesions with positron emission tomography.Radiologe 1994; 34: 588–591.
Liu RS, Shei HR, Feng CF, Chang CP, Liao SQ, Yeh SH. Combined18F FDG and11C acetate PET imaging in diagnosis of pulmonary tuberculosis. Proceedings of the SNM 49th Annual Meeting.J Nucl Med 2002; 43: 127–128. (abstract)
O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient.J Nucl Med 1997; 38: 1575–1583.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, CM., Hsu, CH., Lee, CM. et al. Intense uptake of [F-18]-fluoro-2 deoxy-d-glucose in active pulmonary tuberculosis. Ann Nucl Med 17, 407–410 (2003). https://doi.org/10.1007/BF03006610
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03006610